Fundraising Fox
/People
Sign in

Aaron Nelson

Investor

Partner at Novo Holdings

United States

Find your path to Aaron

412 people in our graph share verified history with Aaron — schools, employers, funds. One of them is your warm intro.

Jeffrey LowunlockedAaron: together at Novo Holdings (2025)
×11Aaron: together at Novo Holdings

About

Aaron Nelson is a Partner in Novo Holdings' US Venture Investments unit, which he joined in June 2025. He was previously Managing Director at the Novartis Venture Fund, where he led Seed and Series A investments in therapeutic drug discovery, and contributed to Novartis's digital health investment program dRx Capital. Earlier he worked across Novartis Research & Development units including Trials of the Future and Investigative Toxicology. He holds a BA from Cornell University, a PhD in Cell and Microbiology from the University of Pennsylvania, and an MD from Tufts University, and conducted post-doctoral studies at the Karolinska Institutet.

Contact· self-published, not guessed

Invests in

BiotechDigital Health

Experience

  1. Novo HoldingsPartnercurrent2025 — presentBoston, Massachusetts, United States
  2. Novartis Venture FundManaging Director2017 — 2025Greater Boston
  3. dRx Capital AGGeneral Partner2015 — 2018virtual
  4. NovartisDirector of Strategic Projects2013 — 2015
  5. NovartisSenior Investigator II, Translational Sciences2009 — 2013
  6. Karolinska InstitutetPost-doctoral Fellow2006 — 2007

Skills & more

Molecular Biology29Animal Models10Pharmacology13Biochemistry11Toxicology4Cell Biology23Clinical Development16Biomarkers7Translational Science4Drug Development35Cell16Biotechnology12
+10 moreIn VivoInfectious DiseasesProtein ChemistryTranslational MedicineImmunoassaysCell CultureIn VitroLife SciencesPublic SpeakingPharmaceutical Industry

Languages English

From Aaron's professional profile.

Investments

Per curated public sources.

Colleagues at Novo Holdings

Abhijeet Lele
Senior Partner at Novo Holdings
Alan Liu
Principal at Novo Holdings
Aleks Engel
Partner at Novo Holdings
Alex Grooten
Senior Manager, Head of Accounting at Novo Holdings
Álvaro Gallego Jurado
Manager at Novo Holdings
Amalie Stokkeland
Senior Associate at Novo Holdings
Amer Sheikh
Partner at Novo Holdings
Amit Kakar
Managing Partner at Novo Holdings

Network5

Anja Koenig
Global Head of NVF at Novartis Venture Fund
Bart Dzikowski
Managing Director, Head of Transactions & Legal at Novartis Venture Fund
Beat Steffen
Managing Director at Novartis Venture Fund
Elena Battistello
Analyst at Novartis Venture Fund
Florian Muellershausen
Managing Director at Novartis Venture Fund

Investors connected to Aaron in public investor directories — a warm-intro map.

Frequently asked questions

Who is Aaron Nelson?
Aaron Nelson is a Partner in Novo Holdings' US Venture Investments unit, which he joined in June 2025. He was previously Managing Director at the Novartis Venture Fund, where he led Seed and Series A investments in therapeutic drug discovery, and contributed to Novartis's digital health investment program dRx Capital. Earlier he worked across Novartis Research & Development units including Trials of the Future and Investigative Toxicology. He holds a BA from Cornell University, a PhD in Cell and Microbiology from the University of Pennsylvania, and an MD from Tufts University, and conducted post-doctoral studies at the Karolinska Institutet.
Where does Aaron Nelson work?
Aaron Nelson is Partner at Novo Holdings.
What does Aaron Nelson invest in?
Aaron Nelson invests in Biotech, Digital Health.
What companies has Aaron Nelson invested in?
Investments tracked here include Averna Therapeutics.
Where did Aaron Nelson go to school?
Aaron Nelson studied at Tufts University School of Medicine (M.D., Medicine); University of Pennsylvania School of Medicine (PhD, Cell and Molecular Biology); Cornell University (B.A., Evolutionary biology).

Same school

Shared employers